Nick is the Wynn professor of human metabolism and is a consultant in diabetes and endocrinology at Imperial College Healthcare NHS Trust. His clinical and academic interest is how technologies can be developed and applied to meet the challenges of living with type 1 diabetes.
Oliver N, 2021, Holding steady, Diabetic Medicine, Vol:38, ISSN:0742-3071
Rilstone S, Reddy M, Oliver N, 2021, A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)., J Diabetes Sci Technol, Vol:15, Pages:666-671
et al., 2021, Anti-interleukin-21 antibody and liraglutide for the preservation of beta-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial, Lancet Diabetes & Endocrinology, Vol:9, ISSN:2213-8587, Pages:212-224
et al., 2021, Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study, Diabetes Technology and Therapeutics, Vol:23, ISSN:1520-9156, Pages:175-186